Prosion
1 known investors
Prosion develops a proprietary therapeutic platform targeting oncology and other diseases with unmet medical needs through novel mechanisms of action. The company focuses on inhibiting tumor growth and metastasis, with pipeline expansion into cardiovascular, infectious, and neurodegenerative disease areas.
Investors · 1
Frequently asked questions
- What does Prosion do?
- Prosion develops a proprietary therapeutic platform targeting oncology and other diseases with unmet medical needs through novel mechanisms of action. The company focuses on inhibiting tumor growth and metastasis, with pipeline expansion into cardiovascular, infectious, and neurodegenerative disease areas.
- Who are Prosion's investors?
- Prosion's investors include Freigeist Capital.